Partnering

MorphoSys has a proven track record of successful alliances. Through its drug discovery partnerships with leading pharmaceutical companies, MorphoSys has created one of the broadest therapeutic antibody pipelines in the industry. The Company is continuously expanding its product pipeline by adding new partnered programs, and by building a portfolio of fully-owned therapeutic antibodies and co-development programs.

 

View Full Pipeline

MorphoSys’s portfolio comprises more than 70 antibody development programs.